Triple 3

Business Summary

Triple 3 has developed a proprietary continuous flow process for extracting collagen from fish. The continuous flow production process will reduce processing costs giving Triple 3 a cost advantage.

Management

Open. Triple 3 is seeking investors and business champions to move this opportunity forward.

Customer Problem

There is a growing international market for the consumption of Type I hydrolyzed marine collagen. Collagen is being used in a variety of settings, including functional foods, cosmetics, and lab research. Customers are searching for lower cost collagen that comes from non-polluted fish sources.

Product / Services

Through a patent-pending continual flow process, Triple 3 Biotechnology will extract and sell marine collagen to wholesale distributors and retailers. Triple 3 will initially begin production at a pilot scale to establish a market presence prior to expanding manufacturing capacity.

Target Market

Triple 3’s target market is wholesalers and retailers selling Type 1 collagen. This is primarily a commodity market, enabling Triple 3 to capitalize on our cost advantages.

Sales/Marketing Strategy

Triple 3 intends to secure purchase orders from a few key wholesalers (marquee customers) and then commence production catered to their specifications.

Business Model

Direct sales to Type 1 collagen distributors and retailers.

Competitors

There is a high level of competition in this commoditized market.

Competitive Advantage

Triple 3 has developed a proprietary production process that employs a continuous work flow, enabling the company to produce product for lower costs. Triple 3 also intends to build manufacturing facilities located near the clean marine input sources in order to create a more efficient supply chain.